Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Recrystallization and Phosphorylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107868105A reveals advanced recrystallization for Sofosbuvir intermediates. Achieves 99.8% purity with improved yield for reliable pharmaceutical supply chains.